State Of Tennessee, Treasury Department Enanta Pharmaceuticals Inc Transaction History

State Of Tennessee, Treasury Department

$27.8 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$20.68 - $39.85 $12,490 - $24,069	604 Added 5.24%	12,122 $259,000
Q1 2023 May 12, 2023	SELL	$38.82 - $54.59 $63,043 - $88,654	-1,624 Reduced 12.36%	11,518 $465,000
Q4 2022 Feb 15, 2023	BUY	$40.77 - $53.73 $15,737 - $20,739	386 Added 3.03%	13,142 $611,000
Q3 2022 Jan 26, 2023	BUY	$48.29 - $71.27 $36,796 - $54,307	762 Added 6.35%	12,756 $662,000
Q2 2022 Aug 15, 2022	SELL	$38.13 - $76.93 $1,067 - $2,154	-28 Reduced 0.23%	11,994 $567,000
Q1 2022 May 11, 2022	BUY	$56.06 - $74.11 $100,571 - $132,953	1,794 Added 17.54%	12,022 $856,000
Q4 2021 Feb 15, 2022	SELL	$60.19 - $97.37 $19,200 - $31,061	-319 Reduced 3.02%	10,228 $764,000
Q3 2021 Nov 12, 2021	SELL	$41.02 - $58.65 $1,476 - $2,111	-36 Reduced 0.34%	10,547 $600,000
Q2 2021 Aug 11, 2021	SELL	$43.76 - $53.11 $8,752 - $10,622	-200 Reduced 1.85%	10,583 $466,000
Q1 2021 May 10, 2021	BUY	$41.69 - $54.95 $21,803 - $28,738	523 Added 5.1%	10,783 $532,000
Q4 2020 Feb 09, 2021	BUY	$41.16 - $47.47 $31,816 - $36,694	773 Added 8.15%	10,260 $432,000
Q2 2020 Aug 13, 2020	SELL	$46.37 - $57.58 $34,545 - $42,897	-745 Reduced 7.28%	9,487 $476,000
Q1 2020 May 15, 2020	SELL	$40.22 - $62.0 $6,837 - $10,540	-170 Reduced 1.63%	10,232 $526,000
Q4 2019 Feb 06, 2020	SELL	$57.95 - $66.61 $80,376 - $92,388	-1,387 Reduced 11.77%	10,402 $643,000
Q3 2019 Oct 30, 2019	BUY	$60.08 - $88.17 $60,620 - $88,963	1,009 Added 9.36%	11,789 $708,000
Q2 2019 Aug 12, 2019	SELL	$81.3 - $97.35 $4,146 - $4,964	-51 Reduced 0.47%	10,780 $909,000
Q1 2019 May 13, 2019	BUY	$69.08 - $105.66 $27,424 - $41,947	397 Added 3.8%	10,831 $1.04 Million
Q4 2018 Feb 11, 2019	BUY	$65.41 - $84.65 $42,516 - $55,022	650 Added 6.64%	10,434 $739,000
Q3 2018 Nov 13, 2018	SELL	$85.46 - $126.37 $7,947 - $11,752	-93 Reduced 0.94%	9,784 $837,000
Q2 2018 Aug 14, 2018	SELL	$81.85 - $120.51 $28,238 - $41,575	-345 Reduced 3.38%	9,877 $1.15 Million
Q1 2018 May 11, 2018	SELL	$57.91 - $92.15 $62,195 - $98,969	-1,074 Reduced 9.51%	10,222 $827,000
Q4 2017 Feb 12, 2018	SELL	$45.65 - $59.37 $12,599 - $16,386	-276 Reduced 2.39%	11,296 $663,000
Q3 2017 Nov 01, 2017	BUY	$37.91 - $46.8 $438,694 - $541,569	11,572	11,572 $542,000

Others Institutions Holding ENTA

# of Institutions

108

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$11.1 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$10.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$9.7 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$7.86 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$5.79 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.

Account